News Sentiment

ALVO sentiment intelligence

Alvotech news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 3.28 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-9.1% over one week, -21.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Alvotech (ALVO) Could Be 76% Below Fair Value On New $75 Million Debt Facility

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -9.1% Price reacting lower
Trend fit Trend inactive -21.3% over four weeks
Fair value -65.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 40
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 10
TradingView 9
Simply Wall Street 3
MT Newswires 3
GlobeNewswire 3
simplywall.st 3
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 7
Balance sheet 5
Analyst action 2
Guidance 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 55
Simply Wall Street Direct company coverage

Alvotech (ALVO) Could Be 76% Below Fair Value On New $75 Million Debt Facility

Alvotech (ALVO) has recently secured a new $75 million debt facility and raised $165 million in equity, providing $240 million for its biosimilar pipeline and commercialization. Despite this new capital, the company's stock has faced significant pressure, falling over 60% in the

Tone
Neutral 50/100
Event
Balance sheet
Published
15 Jul 2026 09:13
Source
Simply Wall Street
Quartr Direct company coverage

Alvotech (ALVO) Barclays 27th Annual Global Healthcare Conference 2025 Summary

This article summarizes Alvotech's presentation at the Barclays 27th Annual Global Healthcare Conference 2025, highlighting its focus on biosimilars, global reach, and financial projections. Key points include an expected 2025 revenue of $600–$800 million, strong performance of i

Tone
Positive 71/100
Event
Earnings
Published
13 Jul 2026 17:11
Source
Quartr
TradingView Direct company coverage

ETFs Investing in Alvotech Stocks

This article lists various ETFs that hold shares of Alvotech (ALVO), a biotechnology company. It provides details such as the market value of Alvotech stocks within each ETF, their weight, issuer, management style, expense ratio, and assets under management. The information aims

Tone
Neutral 50/100
Event
Market update
Published
12 Jul 2026 21:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Alvotech – NASDAQ:ALVO

This page provides financial information for Alvotech (NASDAQ: ALVO), specifically focusing on its enterprise value to EBITDA forward metric. It indicates that the market was closed at the time of the data display. The page is part of TradingView's financial analysis tools, offer

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 12:39
Source
TradingView
Quartr Direct company coverage

Alvotech (ALVO) Q3 2025 earnings summary

Alvotech (ALVO) reported strong Q3 2025 results with $114 million in total revenues, driven by global biosimilar launches, and achieved a profit of $136.5 million for the nine months ended September 30, 2025. The company revised its full-year 2025 revenue guidance to $570–$600 mi

Tone
Positive 64/100
Event
Earnings
Published
10 Jul 2026 11:39
Source
Quartr
TradingView Direct company coverage

Price to sales forward of Alvotech – NASDAQ:ALVO

This article from TradingView focuses on the "Price to sales forward" metric for Alvotech (NASDAQ:ALVO). It appears to be a financial data page showing this specific valuation ratio for the company over different periods, presented without additional commentary or detailed analys

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 15:04
Source
TradingView
TradingView Direct company coverage

Price to book forward of Alvotech – NASDAQ:ALVO

The article focuses on Alvotech (NASDAQ: ALVO)'s "Price to book forward" financial metric. It presents a simple financial data point without further analysis or context. The content is primarily a data placeholder within a financial information platform.

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 04:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Alvotech – SWB:Z45

This page provides financial data for Alvotech (SWB:Z45) on the Stuttgart Stock Exchange, specifically focusing on its enterprise value to EBIT forward. The content indicates that the market was closed with no trades at the time of viewing. It appears to be a financial data prese

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 21:39
Source
TradingView
Moomoo Direct company coverage

Alvotech(ALVO) Stock Options Chain | Quotes & News

This article provides details on Alvotech (ALVO) stock options, including quotes and recent news. It also includes information about the company's financial overview, insider transactions, price performance, and analyst ratings.

Tone
Neutral 50/100
Event
Analyst action
Published
06 Jul 2026 23:09
Source
Moomoo
Simply Wall Street Direct company coverage

Alvotech (ALVO) Secured $240 Million In New Capital, Is The Stock Cheap?

Alvotech (ALVO) recently secured an additional US$240 million in new capital through a credit agreement amendment and earlier equity capital, despite a significant year-to-date share price decline. The company is considered undervalued by Simply Wall St, with a fair value of $13.

Tone
Neutral 50/100
Event
Balance sheet
Published
05 Jul 2026 07:42
Source
Simply Wall Street
TradingView Direct company coverage

Alvotech Warrant 2022-open end on Financial Disclosures & SEC Filings

This article provides access to Alvotech's SEC filings and other financial disclosures, including earnings reports and event transcripts from 2024, 2025, and 2026. The documents offer insights into the company's financial performance, operational updates, biosimilar pipeline, gro

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 05:42
Source
TradingView
The Manila Times Direct company coverage

Transactions of Managers and Closely Associated Persons

Alvotech announced that Celtic Lux Holdings S.a. r.l. pledged 88,940,619 shares and 7,007,321 depository receipts on shares in Alvotech. These transactions occurred on June 26, 2026, and were disclosed via filings with the Luxembourg Commission de Surveillance du Secteur Financie

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 04:17
Source
The Manila Times
GlobeNewswire Direct company coverage

Alvotech further strengthens liquidity by securing term loan facility of $75 million

Alvotech has secured an additional $75 million term loan facility from GoldenTree Asset Management and other lenders, further strengthening its financial position. This follows a recent $165 million equity raise, bringing the total new capital accessed to $240 million. The funds

Tone
Positive 94/100
Event
Balance sheet
Published
03 Jul 2026 23:39
Source
GlobeNewswire
Stock Titan Direct company coverage

Alvotech controller pledges 95.9M shares and depository receipts

Alvotech (ALVO) disclosed that Celtic Lux Holdings pledged 88,940,619 shares and 7,007,321 depository receipts, totaling 95.9 million securities, with the Luxembourg CSSF on June 26, 2026. This transaction is classified as a dealing by managers and closely associated persons, pro

Tone
Negative 39/100
Event
Market update
Published
03 Jul 2026 20:10
Source
Stock Titan
Simply Wall Street Direct company coverage

Should Alvotech’s Expanded US$240 Million Capital Access Require Action From Alvotech (ALVO) Investors?

Alvotech recently secured an additional US$75 million term loan, bringing its total new capital access to US$240 million, alongside a US$165 million equity raise in June 2026. This financial boost aims to fund its biosimilar pipeline and global expansion, addressing short-term li

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:39
Source
Simply Wall Street
Market source Direct company coverage

Alvotech (ALVO) Stock May Be Undervalued Following Its $125 Million Offering

Alvotech (ALVO) stock appears undervalued despite a 64% decline over the past five years, with several valuation tests suggesting it is cheaply priced. The company screens well on valuation metrics according to Simply Wall St, and its P/S ratio of 2.2x is significantly below the

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 15:11
Source
Market source
ABF Journal Direct company coverage

Alvotech Secures Term Loan Facility of $75MM from GoldenTree Asset Management

Alvotech secured an additional $75 million term loan facility from GoldenTree Asset Management, further strengthening its financial position after a recent $165 million equity raise. This financing will support the company's growth strategy, including advancing its biosimilar pip

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 06:40
Source
ABF Journal
Stock Titan Direct company coverage

Alvotech (NASDAQ: ALVO) adds $75M term loan, lifting new capital access to $240M

Alvotech has secured an additional $75 million term loan facility, led by GoldenTree Asset Management, boosting its total new capital access to $240 million when combined with a recent $165 million equity raise. This financing, bearing a 12.50% interest rate and maturing on Decem

Tone
Positive 65/100
Event
Market update
Published
01 Jul 2026 11:39
Source
Stock Titan
Quiver Quantitative Direct company coverage

Alvotech Secures Up to $75 Million Additional Term Loan Facility to Support Pipeline and Global Launches

Alvotech has secured an additional $75 million term loan facility from GoldenTree Asset Management, bringing its total new capital raised to $240 million, including a recent $165 million equity raise. These funds will be used to advance its research and development pipeline, supp

Tone
Positive 69/100
Event
Market update
Published
01 Jul 2026 08:10
Source
Quiver Quantitative
Stock Titan Direct company coverage

Alvotech adds $75M debt after $165M equity raise

Alvotech (NASDAQ: ALVO) has secured an additional $75 million term loan facility, maturing on December 31, 2027, from GoldenTree Asset Management, bearing a 12.50% interest rate payable monthly in cash. This new debt, combined with a recent $165 million equity raise, provides Alv

Tone
Positive 70/100
Event
Balance sheet
Published
01 Jul 2026 08:00
Source
Stock Titan
Stock Titan Direct company coverage

Celtic Lux (ALVO) boosts Alvotech holding with $38M PIPE and $40M loan

Celtic Holdings S.C.A. and Celtic Lux Holdings S.a r.l. have increased their beneficial ownership in Alvotech to approximately 27.5%, now holding 107,450,988 Ordinary Shares. This boost comes from Celtic Lux's acquisition of 10,133,333 Ordinary Shares for $38 million through a PI

Tone
Positive 66/100
Event
Deals and strategy
Published
01 Jul 2026 00:10
Source
Stock Titan
TradingView Direct company coverage

Alvotech Swedish Depository Receipt Repr 1 Sh Actuals & Estimates (TURQUOISE:ALVOS)

This article provides an overview of Alvotech Swedish Depository Receipt Repr 1 Sh (TURQUOISE:ALVOS) on TradingView, focusing on its actuals and estimates. It highlights financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valua

Tone
Neutral 50/100
Event
Analyst action
Published
27 Jun 2026 20:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Alvotech – NASDAQ:ALVOW

This article provides current financial information for Alvotech (NASDAQ:ALVOW), specifically focusing on its price-to-book forward ratio. It highlights the company's financial overview on TradingView, listing it under biotechnology stocks in the USA market. The page shows that t

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 20:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Alvotech – NASDAQ:ALVOW

The article provides financial information for Alvotech (NASDAQ: ALVOW), specifically focusing on its forward price-to-earnings ratio. It is a data-oriented page that shows a period value for this metric. The content is presented by TradingView, a platform for market data and ana

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 17:10
Source
TradingView